A Nonsynonymous SNP in ATG16L1 Predisposes to Ileal Crohn's Disease and Is Independent of CARD15 and IBD5

Gastroenterology

Volumn 132, Issue 5, 2007, Pages 1665-1671

  Prescott, Natalie J ^a   Fisher, Sheila A ^a   Franke, Andre ^b   Hampe, Jochen ^b   Onnie, Clive M ^a   Soars, Dianne ^a   Bagnall, Richard ^a   Mirza, Muddassar M ^a   Sanderson, Jeremy ^c   Forbes, Alastair ^d   Mansfield, John C ^e   Lewis, Cathryn M ^a   Schreiber, Stefan ^b   Mathew, Christopher G ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; PROTEIN; PROTEIN ATG16L1; PROTEIN IBD5; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CROHN DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; UNITED KINGDOM;

EID: 34247566585     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.03.034     Document Type: Article

References (22)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
2. Schreiber S., Rosenstiel P., Albrecht M., Hampe J., and Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6 (2005) 376-388
3. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
4. Mathew C.G., and Lewis C.M. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 13 special review 1 (2004) R161-R168
5. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
6. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
7. Hampe J., Cuthbert A., Croucher P.J., Mirza M.M., Mascheretti S., Fisher S., Frenzel H., King K., Hasselmeyer A., MacPherson A.J., Bridger S., van Deventer S., Forbes A., Nikolaus S., Lennard-Jones J.E., Foelsch U.R., Krawczak M., Lewis C., Schreiber S., and Mathew C.G. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
8. Rioux J.D., Daly M.J., Silverberg M.S., Lindblad K., Steinhart H., Cohen Z., Delmonte T., Kocher K., Miller K., Guschwan S., Kulbokas E.K., O'Leary S., Winchester E., Dewar K., Green T., Stone V., Chow C., Cohen A., Langelier D., Lapointe G., Gaudet D., Faith J., Branco N., Bull S.B., McLeod R.S., Griffiths A.M., Bitton A., Greenberg G.R., Lander E.S., Siminovitch K.A., and Hudson T.K. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29 (2001) 223-228
9. Mirza M.M., Fisher S.A., King K., Cuthbert A.P., Hampe J., Sanderson J., Mansfield J., Donaldson P., Macpherson A.J., Forbes A., Schreiber S., Lewis C.M., and Mathew C.G. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet 72 (2003) 1018-1022
10. Peltekova V.D., Wintle R.F., Rubin L.A., Amos C.I., Huang Q., Gu X., Newman B., Van Oene M., Cescon D., Greenberg G., Griffiths A.M., St George-Hyslop P.H., and Siminovitch K.A. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36 (2004) 471-475
11. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A.T., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., and Cho J.H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
12. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., Albrecht M., Mayr G., de la Vega F., Briggs J., Gunther S., Prescott N.J., Onnie C.M., Hasler R., Sipos B., Fölsch U.R., Lengauer T., Platzer M., Mathew C.G., Krawczak M., and Schreiber S. A genome wide association study of non-synonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39 (2007) 207-211
13. Schmid D., Dengjel J., Schoor O., Stevanovic S., and Munz C. Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med 84 (2006) 194-202
14. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., Mascheretti S., Sanderson J., Forbes A., Mansfield J., Schreiber S., Lewis C.M., and Mathew C.G. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122 (2002) 867-874
15. Onnie C.M., Fisher S.A., Pattni R., Sanderson J., Forbes A., Lewis C.M., and Mathew C.G. Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behaviour: a case-control study and meta-analysis. Inflamm Bowel Dis 12 (2006) 263-271
16. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 170 Suppl (1989) 2-6 discussion 17-19
17. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D.R., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.-F., Casche C., Geboes K., Jewell D.P., Karban A., Loftus E.V., Pena A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinbart A.J., Targan S.R., Vermeire S., and Warren B.F. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
18. Fisher S.A., Hampe J., Onnie C.M., Daly M.J., Curley C., Purcell S., Sanderson J., Mansfield J., Annese V., Forbes A., Lewis C.M., Schreiber S., Rioux J.D., and Mathew C.G. Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Hum Mutat 27 (2006) 778-785
19. Gaya D.R., Russell R.K., Nimmo E.R., and Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet 367 (2006) 1271-1284
20. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., Tysk C., O'Morain C., Gassull M., Binder V., Finkel Y., Modigliani R., Gower-Rousseau C., Macry J., Merlin F., Chamaillard M., Jannot A.S., Thomas G., and Hugot J.P. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70 (2002) 845-857
21. King K., Sheikh M.F., Cuthbert A.P., Fisher S.A., Onnie C.M., Mirza M.M., Pattni R.C., Sanderson J., Forbes A., Mansfield J., Lewis C.M., Roberts R.G., and Mathew C.G. Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15. Hum Mutat 27 (2006) 44-54
22. Deretic V. Autophagy as an immune defense mechanism. Curr Opin Immunol 18 (2006) 375-382